Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Update

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) saw a significant drop in short interest in December. As of December 15th, there was short interest totaling 161,309 shares, a drop of 32.4% from the November 30th total of 238,781 shares. Based on an average daily trading volume, of 106,055 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.5% of the shares of the stock are short sold. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 106,055 shares, the days-to-cover ratio is presently 1.5 days.

Institutional Trading of Rapid Micro Biosystems

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. American Century Companies Inc. acquired a new position in shares of Rapid Micro Biosystems during the 1st quarter worth approximately $31,000. Hudson Bay Capital Management LP bought a new position in shares of Rapid Micro Biosystems in the third quarter valued at $38,000. XTX Topco Ltd acquired a new position in Rapid Micro Biosystems during the second quarter worth $144,000. Dimensional Fund Advisors LP raised its position in Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after acquiring an additional 15,255 shares in the last quarter. Finally, Susquehanna International Group LLP increased its holdings in shares of Rapid Micro Biosystems by 12.6% in the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after purchasing an additional 6,528 shares during the last quarter. Institutional investors and hedge funds own 52.60% of the company’s stock.

Wall Street Analysts Forecast Growth

RPID has been the subject of several research reports. Wall Street Zen cut Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research note on Sunday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $8.00.

Rapid Micro Biosystems Stock Up 5.5%

Shares of RPID traded up $0.15 on Wednesday, hitting $2.90. The company’s stock had a trading volume of 216,249 shares, compared to its average volume of 213,473. The firm’s fifty day moving average price is $3.52 and its 200-day moving average price is $3.32. Rapid Micro Biosystems has a fifty-two week low of $0.87 and a fifty-two week high of $4.50. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $128.53 million, a price-to-earnings ratio of -2.87 and a beta of 1.33.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its earnings results on Friday, November 7th. The company reported ($0.26) EPS for the quarter, hitting the consensus estimate of ($0.26). Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. The firm had revenue of $7.84 million for the quarter, compared to the consensus estimate of $7.60 million. On average, equities research analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current year.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.